Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure
2016 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure
Packer, M.; Holcomb, R.; Abraham, W. T.; Anker, S. ; Dickstein, K.; Filippatos, G. & Krum, H. et al. (2016)
European Journal of Heart Failure, 19(5) pp. 673-681. DOI: https://doi.org/10.1002/ejhf.698
Documents & Media
Details
- Title Variant(s)
- Rationale for the design of the TRUE-AHF trial
- Authors
- Packer, Milton; Holcomb, Richard; Abraham, William T.; Anker, Stefan ; Dickstein, Kenneth; Filippatos, Gerasimos; Krum, Henry; Maggioni, Aldo P.; McMurray, John J.V.; Mebazaa, Alexandre; O'Connor, Christopher; Peacock, Frank; Ponikowski, Piotr; Ruschitzka, Frank; van Veldhuisen, Dirk J.; Holzmeister, Johannes
- Issue Date
- 2016
- Journal
- European Journal of Heart Failure
- ISSN
- 1388-9842
- Language
- English
